Health care industry
CDC is pulling back $11B in Covid funding sent to health departments across the U.S.
A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia. Tami Chappell | Reuters The Centers for Disease Control and Prevention is pulling back $11.4 billion in funds allocated in response to the pandemic to state and community health departments, nongovernment organizations and international recipients, the Department of Health […]
Read More
With 23andMe entering bankruptcy, here’s how to delete your genetic data
Signage at 23andMe headquarters in Sunnyvale, California, U.S., on Wednesday, Jan. 27, 2021. David Paul Morris | Bloomberg | Getty Images 23andMe has officially filed for Chapter 11 bankruptcy protection, which means its assets — including its vast genetic database — will soon be up for sale. The company continues to sell its at-home DNA […]
Read More
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Tom Little | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. […]
Read More
Eli Lilly will soon release key data on its weight loss pill. Here’s why it could be a game-changer
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Patients, doctors and investors will soon learn a lot more about a new, more convenient treatment that could shake up the booming weight loss drug market. Eli Lilly plans to […]
Read More
Novo Nordisk expands discounted Wegovy to all cash-paying U.S. customers
Jakub Porzycki | Nurphoto | Getty Images Novo Nordisk said on Monday all eligible cash-paying customers in the United States can buy its weight-loss drug Wegovy at a discounted price of $499 per month at their local pharmacy. U.S.-listed shares of Novo fell more than 2.5% to $74.92 in premarket trading. Novo has also lost its spot […]
Read More
23andMe files for bankruptcy, Anne Wojcicki steps down as CEO
Anne Wojcicki, co-founder and chief executive officer of 23andme Inc., during the South by Southwest (SXSW) festival in Austin, Texas, US, on Friday, March 10, 2023. Jordan Vonderhaar | Bloomberg | Getty Images Embattled genetic testing company 23andMe, once valued at $6 billion, filed for Chapter 11 bankruptcy protection in Missouri federal court on Sunday […]
Read More
Pope Francis returns to Vatican after five weeks in hospital
Pope Francis waves during his first public appearance in five weeks, on the day he is set to be discharged from Gemelli Hospital, in Rome, Italy, on March 23, 2025. Guglielmo Mangiapane | Reuters Pope Francis returned to the Vatican on Sunday after surviving a five-week battle in hospital against double pneumonia that became the […]
Read More
Pope Francis to be released from the hospital
A rose and and an image of Pope Francis are placed at the statue of late Pope John Paul II outside Gemelli Hospital, where Pope Francis is admitted for treatment, in Rome, Italy, Feb. 27, 2025. Yara Nardi | Reuters Pope Francis is scheduled to be discharged from the hospital on Sunday, his doctors said […]
Read More
Zepbound copycats remain online despite FDA ban
This week was supposed to mark the end of compounding pharmacies making copycat versions of Eli Lilly‘s weight-loss drug Zepbound and its diabetes drug Mounjaro. Online, it doesn’t look like much has changed. Popular websites like Amble, EllieMD, Willow and Mochi Health are all still advertising versions of tirzepatide, the active ingredient in Zepbound. Some, […]
Read More
British pharma giant AstraZeneca to invest $2.5 billion in new China hub
Outside the Macclesfield factory of AstraZeneca. Christopher Furlong | Getty Images News | Getty Images British pharmaceutical giant AstraZeneca on Friday said that it will invest $2.5 billion in a research and development center in Chinese capital Beijing. The new hub is expected to take AstraZeneca’s Beijing workforce to around 1,700 employees. Don’t miss AstraZeneca’s CEO […]
Read More